BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2008
View Archived Issues
Ranbaxy patents novel muscarinic receptor antagonists
Read More
New analgesic agents imparted in recent patent literature
Read More
Novel treatments for dermatological disorders disclosed in recent patents
Read More
Sanofi pasteur's acquisition of Acambis completed
Read More
Manageable levels of neuropathy in breast cancer patients receiving eribulin
Read More
Novel GIP antagonist shows efficacy in preclinical models of obesity and type 2 diabetes
Read More
Positive phase I interim results of XOMA-052 in type 2 diabetes
Read More
Almirall receives payment from Forest as part of aclidinium collaboration
Read More
Arana Therapeutics provides update on recent pipeline activity
Read More
Safety results presented at the WSC from the V-10153 stroke thrombolysis trial
Read More
LAU-0901 neuroprotective in a rat model of focal cerebral ischemia
Read More
BioMS receives milestone payment based on positive review of MAESTRO-01 trial
Read More
MAP completes enrollment in phase III nebulized budesonide trial in children with asthma
Read More
ChemBridge enters into new discovery alliance with AstraZeneca
Read More
Discovery Laboratories completes response to FDA approvable letter for Surfaxin
Read More
BIO-11006 shows promise as a COPD treatment
Read More
Dyax completes BLA for DX-88 in hereditary angioedema
Read More
Inspire requests SPA process for Prolacria for dry eye
Read More
Independent Data Safety Monitoring supports continuation of Iluvien trial
Read More
Cellerant Therapeutics receives contract for acute radiation syndrome treatment
Read More
CHMP issues positive opinion for olanzapine long-acting injection in schizophrenia
Read More
Concert commences phase I CTP-347 trial in healthy volunteers
Read More
FDA approves Nasacort AQ Nasal Spray for children with allergic rhinitis
Read More
ImClone starts enrollment in phase II IMC-A12 trial in advanced breast cancer
Read More
RegeneRx enrolls first subject in phase Ib RGN-352 trial
Read More
Xenome evaluates XEN-2174 in phase II trial in acute pain
Read More
Thallion enrolls first patient in phase II TLN-4601 trial; FDA approves trial in U.S.
Read More